Valuation
Market cap
$380.6B
P/E (ttm)
105.1
Forward P/E
13.3
Beta (5y)
0.30
Shares out
1,766.8M
Div yield
321.00%
Profitability & returns
ROE
—
Net margin
5.8%
FCF margin
33.1%
Debt / equity
—
Trading information
Last price
$215.40
Day range
$215.40 – $215.40
52-wk range
$190.75 – $237.11
Avg volume
6.6M
RSI (2)
53.0
TAO zone
Neutral
Company
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYQ
Next earnings
2026-07-30
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to…